Skip to main content

Six months after launch, Cambridge cancer startup files for IPO

Deerfield Capital's latest cancer venture is raring to hit the public markets, just six months after emerging from stealth.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.